The lock-up is over
Fujian Haixi Pharmaceuticals says 1,981,700 H shares are subject to a lock-up agreement ending on April 19, 2026. Translation: the shares that were previously stuck in share jail are about to re-enter the market.
Why you should care
When lock-ups expire, the usual investor question is simple: who’s going to sell, and how hard? More supply hitting the tape can pressure the stock, especially if the holders are big names or early backers with a profit to take.
What’s in the fine print
- The lock-up began on October 17, 2025 and runs 184 days
- Controlling shareholders agreed to staged expirations on April 19, 2026 and October 19, 2026
- The cornerstone investor is locked until April 19, 2026
- Other existing shareholders are tied up until October 19, 2026
Big picture
This isn’t the kind of headline that changes the company’s science overnight, but it can absolutely change the stock’s mood. Sometimes the market shrugs; sometimes it treats a lock-up expiry like a crowd at a concert spotting the fire exit.